/
/
/

Nephrocare Health Services Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Jun 2025Mar 2025Dec 2024
₹282 Cr₹266 Cr₹260 Cr₹228 Cr₹219 Cr₹197 Cr
₹7 Cr₹12 Cr₹3 Cr₹7 Cr₹4 Cr₹5 Cr
₹289 Cr₹277 Cr₹263 Cr₹234 Cr₹223 Cr₹203 Cr
₹242 Cr₹238 Cr₹221 Cr₹200 Cr₹187 Cr₹171 Cr
₹71 Cr₹65 Cr₹64 Cr₹54 Cr₹55 Cr₹49 Cr
₹2 Cr₹3 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr
₹45 Cr₹36 Cr₹36 Cr₹29 Cr₹30 Cr₹26 Cr
₹36 Cr₹33 Cr₹32 Cr₹24 Cr₹25 Cr₹20 Cr

Share Price Live Stats

Open (₹)711.85
Volume (₹)89,446.00
High (₹)720.00
Upper Circuit848.10
Low (₹)702.65
Lower Circuit565.40
Prev Close706.75
52W High (₹)769.75
Price702.85
52W Low (₹)446.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)7108.01 Cr
Div. Yield (%)0.00
PE Ratio92.50
Debt to Equity0.02
Price to Book4.62
Book Value109.48
EPS (TTM)7.64
Face Value2.00
ROE (%)9.22

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
NEPHROPLUSNSE
LTP
1W Low
1W High
Market cap (₹)
8673.5-165 (-1.87%)
8640
8902
1,26,300Cr
998.9-15.2 (-1.50%)
985.50
1042.10
96,763Cr
724.55-47.1 (-6.10%)
702
784
95,496Cr
910.8-15.95 (-1.72%)
893
929
68,901Cr
785.4+37 (4.94%)
745.05
792.05
68,592Cr
1871-61.1 (-3.16%)
1870.50
1949.60
38,439Cr
1480.3+8.1 (0.55%)
1410
1500.10
38,149Cr
1878.3-52.8 (-2.73%)
1855.70
1963
32,259Cr
766.05-4.95 (-0.64%)
748.30
778.55
32,231Cr
510.5+2.7 (0.53%)
502
524.50
16,249Cr
702.85+10.5 (1.52%)
669
720
7,108Cr

Key Highlights of Nephrocare Health Services Ltd’s P&L

In 2026-03-31, Nephrocare Health Services Ltd reported total revenue of ₹1023.36Cr, compared with ₹769.91Cr in 2025-03-31, reflecting Nephrocare Health Services Ltd turnover.

Depreciation was ₹90.67Cr and finance costs were ₹60.24Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹97.47Cr in 2026-03-31 as compared to ₹87.44Cr in 2025-03-31.

Net Profit (PAT) was ₹76.84Cr in 2026-03-31 compared with ₹67.1Cr in 2025-03-31.

Earnings per share (EPS) were ₹7.66 in 2026-03-31, compared with ₹380.15 in 2025-03-31.